Partner Content Partner Content Highly Potent Active Pharmaceutical Ingredients - Under 2 We... HPAPI 2018
Partner Content Partner Content SMi’s HPAPI 2018 Conference: Exclusive Interview Released wi... HPAPI 2018
Partner Content Partner Content Introducing the 2nd Annual HPAPI Conference this May 2018 2nd Annual HPAPI Conference this May 2018
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.